The Treatment of Unresectable Liver Cancer With E-TACE Combined With Donafenib：A Prospective, Single-arm, Multicenter, Observational Study
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Radiotherapy Combined With QL1706 and Bevacizumab for Unresectable Non-metastatic Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Effects of Antrodia Cinnamomea on the Hepatoma Patients After Transcatheter Hepatic Artery Chemoembolization
- Status
- RECRUITING
- Phase
- NA
A Study of ZW251 in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
ThinkRadial: A Prospective Study of Transradial deTACE in HCC Patients
- Status
- COMPLETED
- Phase
- N/A
The Safety, Efficacy, and Immune Response of Multimodal Thermal Therapy in the Treatment of Malignant Liver Tumors
- Status
- RECRUITING
- Phase
- NA
Gecacitinib Combined With Donafenib and PD-1 Inhibitor as Immune Rechallenge Therapy for Unresectable Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
- Status
- RECRUITING
- Phase
- PHASE1
Y-90 Treatment Response Using Transarterial Radioembolization
- Status
- RECRUITING
- Phase
- PHASE2
A Single-Arm, Multicenter, Exploratory Clinical Study of TACE Combined With Iparomlimab and Tuvonralimab Injection (QL1706) and Lenvatinib for Perioperative Treatment of Resectable Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
AHCC® as Immune Modulator in Cancer Patients Treated With Immunotherapy
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Trial Utilizing 18F-FS PG PET to Guide Therapy in Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1
Yttrium-90 Radiation Segmentectomy for Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- NA
TACE Combined With Anti-PD-1 Antibody in Patients With Advanced Hepatocellular Carcinoma: Study on Efficacy and Immune Microenvironment
- Status
- RECRUITING
- Phase
- N/A
Curative Therapy After Atezolizumab and Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- N/A
Durvalumab and Tremelimumab With Lenvatinib as First-line Treatment in Patients With Unresectable Hepatocellular Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Comparing the Combination of Trastuzumab and Regorafenib With Regorafenib Monotherapy for Advanced Hepatocellular Carcinoma After First-line Treatment
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Tauroursodeoxycholic Acid Combined With PD-1/PD-L1 Immunotherapy in Advanced Hepatocellular Carcinoma: A Prospective Study
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + SBRT for BCLC-C HCC With PVTT and/or Oligometastases
- Status
- RECRUITING
- Phase
- PHASE2